EVOTEC SE - ADR
EVOTEC SE - ADR logo
EVO

EVOTEC SE - ADR (EVO)

$9.853.05%

Market is closed
– opens on 8 PM, 31 Jan 2023
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$9.81
Day's Range
$10.06
$7.8
52-Week Range
$21.55
1 month return20.86%
3 month return1.26%
1 year return50.63%
5 year return212.59%

Insights on EVOTEC SE - ADR

  • Increasing Revenue

    Revenue is up for the last 3 quarters, 164.67M → 173.88M (in $), with an average increase of 2.7% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -27.93M → -47.27M (in $), with an average decrease of 69.2% per quarter

  • Vs Neurocrine Biosciences, Inc.

    In the last 1 year, Neurocrine Biosciences, Inc. has given 37.0% return, outperforming this stock by 87.6%

Analyst Recommendation

based on 15 analysts ratings

Buy
73%
Buy
20%
Hold
6%
Sell

Based on 15 Wall street analysts offering stock ratings for EVOTEC SE - ADR(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 67.51%

Current

$9.85

Target

$16.5

Recommendation Trend

Based on 15 analyst

Current1M Ago3M Ago
Buy
11
11
12
Hold
3
3
3
Sell
1
1
1
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization3.7B
Book Value$3.48
Dividend Share0.0
Dividend Yield0.0%
Earnings Per Share (EPS)0.02
PE Ratio508.0
Wall Street Target Price16.5

Valuation

Trailing PE508.0
Forward PE89.29
Price/Book (mrq)2.3
Enterprise Value2.7B
Enterprise Value/Revenue3.84
Enterprise Value/Ebitda-19.09

Technicals

Beta0.96
50 Day MA8.75
200 Day MA10.93

Institutional Holdings

Artisan Partners Limited Partnership

0.65%

Artal Group S A

0.32%

Federated Hermes Inc

0.21%

Millennium Management LLC

0.1%

Zurcher Kantonalbank

0.06%

JANE STREET GROUP, LLC

0.02%

Company Information

Evotec SE is a publicly listed drug discovery and development company headquartered in Hamburg, Germany. The company operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture capitalists.
OrganizationEVOTEC SE - ADR
Employees4715
CEODr. Werner Lanthaler M.B.A., MBA, MPA, Ph.D.
IndustryMiscellaneous

Discover more

Frequently Asked Questions

What is EVOTEC SE - ADR share price today?

Can Indians buy EVOTEC SE - ADR shares?

How can I buy EVOTEC SE - ADR shares from India?

Can Fractional shares of EVOTEC SE - ADR be purchased?

What are the documents required to start investing in EVOTEC SE - ADR stocks?

What are today’s High and Low prices of EVOTEC SE - ADR?

What are today’s traded volumes of EVOTEC SE - ADR?

What is today’s market capitalisation of EVOTEC SE - ADR?

What is the 52 Week High and Low Range of EVOTEC SE - ADR?

How much percentage EVOTEC SE - ADR is down from its 52 Week High?

How much percentage EVOTEC SE - ADR is up from its 52 Week low?

What are the historical returns of EVOTEC SE - ADR?

Who is the Chief Executive Officer (CEO) of EVOTEC SE - ADR?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*